Barrett A, Cullum V
Br J Pharmacol. 2008; 34(1):43-55.
PMID: 19108278
PMC: 1703450.
DOI: 10.1111/j.1476-5381.1968.tb07949.x.
HARMS H, de Vente J, Zaagsma J
Br J Clin Pharmacol. 1982; 13(Suppl 2):181S-186S.
PMID: 6125168
PMC: 1402182.
DOI: 10.1111/j.1365-2125.1982.tb01908.x.
ARESKOG N, Adolfsson L
Br Med J. 1969; 2(5657):601-3.
PMID: 5798470
PMC: 1983612.
DOI: 10.1136/bmj.2.5657.601.
Papp J, VAUGHAN WILLIAMS E
Br J Pharmacol. 1969; 36(1):178P-179P.
PMID: 5768092
PMC: 1703556.
Brick I, Hutchison K, McDevitt D, Roddie I, Shanks R
Br J Pharmacol. 1968; 34(1):127-40.
PMID: 4877600
PMC: 1703393.
DOI: 10.1111/j.1476-5381.1968.tb07956.x.
Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
Cuthbert M, Owusu-Ankomah K
Br J Pharmacol. 1971; 43(3):639-48.
PMID: 4400530
PMC: 1665788.
DOI: 10.1111/j.1476-5381.1971.tb07193.x.
The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.
LOUBATIERES A, Mariani M, Sorel G, Savi L
Diabetologia. 1971; 7(3):127-32.
PMID: 4397807
DOI: 10.1007/BF01212541.
General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.
Brunner H, HEDWALL P, Meier M
Naunyn Schmiedebergs Arch Pharmakol. 1971; 269(2):219-31.
PMID: 4397722
DOI: 10.1007/BF01003039.
Comparative chronotropic activity of beta-adrenoceptive antagonists.
Barrett A, Carter J
Br J Pharmacol. 1970; 40(3):373-81.
PMID: 4395742
PMC: 1703170.
DOI: 10.1111/j.1476-5381.1970.tb10619.x.
Controlled trial of oxprenolol and practolol in hypertension.
LEISHMAN A, THIRKETTLE J, Allen B, Dixon R
Br Med J. 1970; 4(5731):342-4.
PMID: 4394369
PMC: 1819715.
DOI: 10.1136/bmj.4.5731.342.
Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G, Clayton G
Br Med J. 1970; 2(5706):399-402.
PMID: 4392983
PMC: 1700305.
DOI: 10.1136/bmj.2.5706.399.
Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle.
Bowman W, Nott M
Br J Pharmacol. 1970; 38(1):37-49.
PMID: 4391735
PMC: 1702637.
DOI: 10.1111/j.1476-5381.1970.tb10334.x.
A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
Papp J, Williams E
Br J Pharmacol. 1969; 37(2):391-9.
PMID: 4390670
PMC: 1703656.
DOI: 10.1111/j.1476-5381.1969.tb10576.x.
Assessment of selective beta-adrenoceptor blockade in man.
Briant R, Dollery C, Fenyvesi T, George C
Br J Pharmacol. 1973; 49(1):106-14.
PMID: 4150760
PMC: 1776418.
DOI: 10.1111/j.1476-5381.1973.tb08272.x.
Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
ADAM K, Pullman L, SCHOLFIELD P
Br J Pharmacol. 1973; 49(3):560-3.
PMID: 4149697
PMC: 1776481.
DOI: 10.1111/j.1476-5381.1973.tb17268.x.
Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.
ASSEM E, SCHILD H
Br J Pharmacol. 1971; 42(4):620-30.
PMID: 4107257
PMC: 1665737.
DOI: 10.1111/j.1476-5381.1971.tb07146.x.
The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.
Daly M, Flook J, Levy G
Br J Pharmacol. 1975; 53(2):173-81.
PMID: 238697
PMC: 1666304.
DOI: 10.1111/j.1476-5381.1975.tb07347.x.
Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
Zaagsma J, Meems L, Boorsma M
Naunyn Schmiedebergs Arch Pharmacol. 1977; 298(1):29-36.
PMID: 18685
DOI: 10.1007/BF00510983.
